NCT01150513 2021-02-09
Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer
ChineseAMS
Phase 2/3 Completed
ChineseAMS
ChineseAMS
ChineseAMS
ChineseAMS
ChineseAMS
ChineseAMS
PIMERIndia